Bioventus BVS Net debt / EBITDA

Net debt / EBITDA at other companies

StrykerSYK

1.9×-1.3×

Zimmer Biomet HoldingsZBH

3.1×0.0×

Xtant Medical HoldingsXTNT

0.3×—

MedtronicMDT

2.9×-0.2×

Globus MedicalGMED

-0.4×-2.6×

EnovisENOV

8.9×+6.0×

FAQ

What is Bioventus's net debt / EBITDA?

Bioventus (BVS) reported net debt / EBITDA of 2.3× in Q2 2026.

How has Bioventus's net debt / EBITDA changed year-over-year?

Bioventus's net debt / EBITDA decreased by 54.1% year-over-year, from 4.9× to 2.3×.

What is the long-term trend for Bioventus's net debt / EBITDA?

Over 2 years (2020 to 2025), Bioventus's net debt / EBITDA has grown at a 4.5% compound annual growth rate (CAGR), from 2.4× to 2.6×.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.